CytomX Therapeutics, Inc. (CTMX)
NASDAQ·Healthcare·Biotechnology
$2.31
-0.22%
Mkt Cap $546.93M
Analyst Ratings
Buy
3
Hold
0
Sell
0
Price Target (22 analysts)
$8.50
Range $6.00 – $11.00
Implied Upside
+268.0%
Consensus $8.50 vs current $2.31
NASDAQ·Healthcare·Biotechnology
$2.31
-0.22%
Mkt Cap $546.93M
Buy
3
Hold
0
Sell
0
Price Target (22 analysts)
$8.50
Range $6.00 – $11.00
+268.0%
Consensus $8.50 vs current $2.31